$-0.33 EPS Expected for Apollo Endosurgery, Inc. (APEN)

February 15, 2018 - By Marguerite Chambers

 $ 0.33 EPS Expected for Apollo Endosurgery, Inc. (APEN)

Analysts expect Apollo Endosurgery, Inc. (NASDAQ:APEN) to report $-0.33 EPS on March, 14.They anticipate $34.68 EPS change or 99.06 % from last quarter’s $-35.01 EPS. After having $-0.32 EPS previously, Apollo Endosurgery, Inc.’s analysts see 3.13 % EPS growth. The stock decreased 1.01% or $0.065 during the last trading session, reaching $6.405. About 14,179 shares traded. Apollo Endosurgery, Inc. (NASDAQ:APEN) has declined 51.87% since February 15, 2017 and is downtrending. It has underperformed by 68.57% the S&P500.

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for the treatment of obesity. The company has market cap of $110.74 million. The firm offers endo-bariatric products, such as Orbera intragastric balloon system, a non-surgical alternative for the treatment of overweight and obese adults; and OverStitch, an endoscopic suturing system that enables endoscopic procedures by allowing physicians to place full-thickness sutures and secure the approximation of tissue through an Olympus dual-channel flexible endoscope. It currently has negative earnings. It also provides surgical products, including Lap-Band system, a system designed to provide minimally invasive long-term treatment of obesity; and accessories used in laparoscopic bariatric surgeries.

More notable recent Apollo Endosurgery, Inc. (NASDAQ:APEN) news were published by: Businesswire.com which released: “Apollo Endosurgery, Inc. Announces Pricing of $31 Million Public Offering” on July 20, 2017, also Seekingalpha.com with their article: “Apollo Endosurgery’s (APEN) CEO Todd Newton on Q3 2017 Results – Earnings Call …” published on October 28, 2017, Quotes.Wsj.com published: “Apollo Endosurgery Inc. APEN (US: Nasdaq)” on December 30, 2016. More interesting news about Apollo Endosurgery, Inc. (NASDAQ:APEN) were released by: Marketwatch.com and their article: “Apollo Endosurgery Inc.” published on January 17, 2017 as well as Businesswire.com‘s news article titled: “Intragastric Balloon, a Non-Surgical Solution to Assist Patients in Weight Loss” with publication date: August 06, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.